Comprehensive solutions for your Treg mouse and human research

Recorded webinar

This webinar provides insights into our comprehensive solutions for Treg mouse and human research. We will take a look at our whole Treg research products and workflows, allowing you to find the best solutions for your Treg mouse and human research.  

We will share insights into: 

  • Isolating a range of fully functional Tregs subsets directly from whole blood, blood products and tissues.
  • Easy cultivation, activation and expansion of your Tregs by conserving the functional and phenotypical characterization.
  • Our latest flow analysis solutions and antibody panels, as well as our optimized detection kits.
video preview Play video

Comprehensive solutions for your Treg mouse and human research

Regulatory T cells (Tregs) are an important T cell subpopulation that maintains immunological homeostasis. Today, Treg-based therapy shows an enormous potential for treatment of autoimmune and auto-inflammatory disorders, acute and chronic infection, allergy, metabolic inflammation, transplantation, and cancer. Therefore, it is crucial to provide reliable and trustworthy research materials alongside an easily translatable workflow into the clinic. This webinar explores our innovative tools to support Treg research at every step.   

About the presenter

Niloufar Monhasery received her Ph.D. in Biology from the University of Düsseldorf, Germany, in 2016. She continued her studies in cancer research as a postdoctoral fellow at the Princess Margaret Cancer Center in Toronto and then at the University Hospital of Cologne, before joining Miltenyi Biotec as a Global Product Manager for T Cell Immunology. 

Niloufar Monhasery, Miltenyi Biotec